<i>miR-429-3p</i> mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease.

Authors:
Luo M; Pang Y; Li J; Yi L; Wu B and 8 more

Journal:
Acta Pharm Sin B

Publication Year: 2023

DOI:
10.1016/j.apsb.2023.10.015

PMCID:
PMC10840427

PMID:
38322333

Journal Information

Full Title: Acta Pharm Sin B

Abbreviation: Acta Pharm Sin B

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest The authors declare no conflicts of interest."

Evidence found in paper:

"This work was supported by grants from the 10.13039/100014717National Natural Science Foundation of China (32371030, 82371194, 82071395 and 82001158), the 10.13039/501100005230Natural Science Foundation of Chongqing (CSTB2022NSCQ-LZX0010 and cstc2021ycjh-bgzxm0186, China), the Scientific and Technological Innovation Project for the Construction of Chengdu-Chongqing Economic Circle (KJCXZD2020021, China) and CQMU Program for Youth Innovation in Future Medicine (W0044, China). We are grateful to other members in the Dong laboratory for the technical support and helpful suggestion."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025